Premium
Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 ( Br. J. Haematol . 2012; 157: 47–58): use of direct acting oral anticoagulants
Author(s) -
Arachchillage Deepa R. J.,
Gomez Keith,
Alikhan Raza,
Anderson Julia A. M.,
Lester Will,
Laffan Mike
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16308
Subject(s) - medicine , rivaroxaban , antiphospholipid syndrome , apixaban , thrombosis , lupus anticoagulant , gastroenterology , warfarin , surgery , atrial fibrillation
Deepa R. J. Arachchillage, Keith Gomez, Raza Alikhan, Julia A. M. Anderson, Will Lester, and Mike Laffan On behalf of British Society for Haematology Haemostasis and Thrombosis Taskforce Department of Haematology, Imperial College Healthcare NHS Trust, Centre for Haematology, Imperial College London, Katherine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff, Department of Haematology, Royal Infirmary of Edinburgh, Edinburgh and Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK